Factors Influencing Development of New Veterinary Medicine Oncology Products

Presenation made by Karen Greenwood, BSc, Director, Companion Animal Internal Medicine Unit at Pfizer Animal Health at the 2011 National Parent Club Canine Health Conference hosted by the AKC Canine Health Foundation.

Presenation Abstract:
The presentation will cover the process involved in identifying and registering new oncology treatments for canines and the factors that influence successful registration and launch. This will include observations on the challenge and complexity of development for agents specifically developed for pets versus off-label use of human health products, the MUMS (minor use, minor species) process as it relates to oncology, and the benefits of translational oncology for canine cancer patients.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $50
  • $100
  • $250
  • $1000
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty

© 2018 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software